Dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia, first-degree relatives and healthy controls: a meta-analysis.
BACKGROUND
Several studies have reported the presence of dyskinesia and parkinsonism in antipsychotic-naive patients with schizophrenia as well as in their first-degree relatives. These movement disorders may therefore form an integral part of the illness and its (genetic) liability.


METHODS
A systematic search was conducted in the Medline, EMBASE, and PsychINFO databases to identify studies reporting on dyskinesia and parkinsonism assessed in antipsychotic-naive patients with schizophrenia (n = 213) and controls (n = 242) and separately in nonill first-degree relatives (n = 395) and controls (n = 379). Effect sizes were pooled using random-effect models to calculate odds ratios (ORs) to compare the risk of these movement disorders among patients and healthy relatives each with matched controls.


RESULTS
Antipsychotic-naive schizophrenia was found to be strongly associated with dyskinesia (OR: 3.59, 95% confidence interval [CI]: 1.53-8.41) and parkinsonism (OR: 5.32, 95% CI: 1.75-16.23) compared with controls. Dyskinesia and parkinsonism were also significantly more prevalent in healthy first-degree relatives of patients with schizophrenia as compared with healthy controls (OR: 1.38, 95% CI: 1.06-1.81, and OR: 1.37, 95% CI: 1.05-1.79, respectively).


CONCLUSIONS
The results suggest that movement disorders, and by inference abnormalities in the nigrostriatal pathway, are not only associated with schizophrenia itself but may also be related to the (genetic) risk of developing the disease.
Koning
Jeroen P F
JP
Psychiatric Center, Symfora groep, Amersfoort, The Netherlands. jpf.koning@symfora.nl
Tenback
Diederik E
DE
van Os
Jim
J
Aleman
André
A
Kahn
René S
RS
van Harten
Peter N
PN
D015897:Comorbidity; D003342:Corpus Striatum / Q000503:physiopathology; D020820:Dyskinesias / Q000453:epidemiology* / Q000235:genetics* / Q000503:physiopathology; D020022:Genetic Predisposition to Disease / Q000235:genetics; D006801:Humans; D009434:Neural Pathways / Q000503:physiopathology; D016017:Odds Ratio; D020734:Parkinsonian Disorders / Q000453:epidemiology* / Q000235:genetics* / Q000503:physiopathology; D012016:Reference Values; D012306:Risk; D012559:Schizophrenia / Q000453:epidemiology* / Q000235:genetics* / Q000503:physiopathology; D013378:Substantia Nigra / Q000503:physiopathology